Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEHYT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,844
Award facts
- Contract value 100% obligated
- $11,844.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,844.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on October 24, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V program is a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. This specific delivery order was placed without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group's contract authorizes the company to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support military healthcare operations. The company's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. The delivery order is scheduled for completion by October 27, 2025, and represents one of numerous orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division, demonstrating the contractor's established performance in fulfilling the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEHYT?
SPE2DU26FEHYT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DU26FEHYT worth?
The government has obligated $11,844 on SPE2DU26FEHYT.
Is contract SPE2DU26FEHYT an order under another contract?
Yes. SPE2DU26FEHYT is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHYT competed?
The extent of competition for SPE2DU26FEHYT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award